Loading
No insider purchase over the last 90 days. The latest was filed 11 Mar 2026.
Liven Pharma Limited is a listed company. Its directors and officers file their transactions with PSX (SECP). 0 insiders has disclosed 37 filings since 25 October 2025.
Both sides are active: 4 purchases worth €6,566 and 31 sales worth €250k, from 0 insiders and 0 insiders respectively. Sales outweigh purchases by €244k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The filings include the largest sale, €75k, on 11 December 2025.
The latest purchase dates back some time: it was published 228 days ago, on 11 March 2026. Between a trade and the moment it shows up on PSX (SECP), the median delay is 9 days. Until a filing is published, the market cannot know about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
Compared with its exchange (281 companies, median 3 filings), a count of 37 filings is above the norm. The full history, which starts in 2025, counts 4 purchases against 31 sales.
This summary is built from PSX (SECP) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
25 of 37 declarations
Liven Pharma Limited is a company focused on developing innovative pharmaceutical solutions. It is listed on the XKAR market.